Lamin A Is an Endogenous SIRT6 Activator and Promotes SIRT6-Mediated DNA Repair

Cell Reports

Volumn 13, Issue 7, 2015, Pages 1396-1406

  Ghosh, Shrestha ^a,b   Liu, Baohua ^a,c   Wang, Yi ^a   Hao, Quan ^a   Zhou, Zhongjun ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (China)

^c Shenzhen University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEACETYLASE; LAMIN; LAMIN A; LAMIN C; SIRTUIN 6; DNA DEPENDENT PROTEIN KINASE; PROTEIN BINDING; SIRT6 PROTEIN, HUMAN; SIRTUIN;

ADENOSINE DIPHOSPHATE RIBOSYLATION; AGING; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELLULAR DISTRIBUTION; CHROMATIN; CONTROLLED STUDY; DEACETYLATION; DNA DAMAGE; DNA REPAIR; EMBRYO; ENZYME ACTIVITY; HISTONE DEACETYLATION; HISTONE MODIFICATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROGERIA; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; CHEMISTRY; ENZYME ACTIVATION; HEK293 CELL LINE; METABOLISM; PHYSIOLOGY; PROTEIN TRANSPORT;

DNA DAMAGE; DNA REPAIR; DNA-ACTIVATED PROTEIN KINASE; ENZYME ACTIVATION; HEK293 CELLS; HUMANS; LAMIN TYPE A; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN TRANSPORT; SIRTUINS;

EID: 84947303470     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2015.10.006     Document Type: Article

References (58)

1. Beauharnois J.M., Bolívar B.E., Welch J.T. Sirtuin 6: a review of biological effects and potential therapeutic properties. Mol. Biosyst. 2013, 9:1789-1806.
2. Cau P., Navarro C., Harhouri K., Roll P., Sigaudy S., Kaspi E., Perrin S., Giovannoli A.D.S., Lévy N. Nuclear matrix, nuclear envelope and premature aging syndromes in a translational research perspective. Semin. Cell. Dev. Biol. 2014, 29:125-147.
3. Ciska M., Moreno Díaz de la Espina S. The intriguing plant nuclear lamina. Front. Plant Sci. 2014, 5:166.
4. Dominy J.E., Lee Y., Jedrychowski M.P., Chim H., Jurczak M.J., Camporez J.P., Ruan H.B., Feldman J., Pierce K., Mostoslavsky R., et al. The deacetylase Sirt6 activates the acetyltransferase GCN5 and suppresses hepatic gluconeogenesis. Mol. Cell 2012, 48:900-913.
5. Drouet J., Delteil C., Lefrançois J., Concannon P., Salles B., Calsou P. DNA-dependent protein kinase and XRCC4-DNA ligase IV mobilization in the cell in response to DNA double strand breaks. J. Biol. Chem. 2005, 280:7060-7069.
6. Elhanati S., Kanfi Y., Varvak A., Roichman A., Carmel-Gross I., Barth S., Gibor G., Cohen H.Y. Multiple regulatory layers of SREBP1/2 by SIRT6. Cell Rep. 2013, 4:905-912.
7. Eriksson M., Brown W.T., Gordon L.B., Glynn M.W., Singer J., Scott L., Erdos M.R., Robbins C.M., Moses T.Y., Berglund P., et al. Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature 2003, 423:293-298.
8. Etchegaray J.P., Zhong L., Mostoslavsky R. The histone deacetylase SIRT6: at the crossroads between epigenetics, metabolism and disease. Curr. Top. Med. Chem. 2013, 13:2991-3000.
9. Feldman J.L., Baeza J., Denu J.M. Activation of the protein deacetylase SIRT6 by long-chain fatty acids and widespread deacylation by mammalian sirtuins. J. Biol. Chem. 2013, 288:31350-31356.
10. Gertler A.A., Cohen H.Y. SIRT6, a protein with many faces. Biogerontology 2013, 14:629-639.
11. Giblin W., Skinner M.E., Lombard D.B. Sirtuins: guardians of mammalian healthspan. Trends Genet. 2014, 30:271-286.
12. Gil R., Barth S., Kanfi Y., Cohen H.Y. SIRT6 exhibits nucleosome-dependent deacetylase activity. Nucleic Acids Res. 2013, 41:8537-8545.
13. Goldman R.D., Shumaker D.K., Erdos M.R., Eriksson M., Goldman A.E., Gordon L.B., Gruenbaum Y., Khuon S., Mendez M., Varga R., Collins F.S. Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson-Gilford progeria syndrome. Proc. Natl. Acad. Sci. USA 2004, 101:8963-8968.
14. Hale J.S., Frock R.L., Mamman S.A., Fink P.J., Kennedy B.K. Cell-extrinsic defective lymphocyte development in Lmna(-/-) mice. PLoS ONE 2010, 5:e10127.
15. Hennekam R.C. Hutchinson-Gilford progeria syndrome: review of the phenotype. Am. J. Med. Genet. A. 2006, 140:2603-2624.
16. Jiang H., Khan S., Wang Y., Charron G., He B., Sebastian C., Du J., Kim R., Ge E., Mostoslavsky R., et al. SIRT6 regulates TNF-α secretion through hydrolysis of long-chain fatty acyl lysine. Nature 2013, 496:110-113.
17. Kaidi A., Weinert B.T., Choudhary C., Jackson S.P. Human SIRT6 promotes DNA end resection through CtIP deacetylation. Science 2010, 329:1348-1353.
18. Kanfi Y., Naiman S., Amir G., Peshti V., Zinman G., Nahum L., Bar-Joseph Z., Cohen H.Y. The sirtuin SIRT6 regulates lifespan in male mice. Nature 2012, 483:218-221.
19. Kawahara T.L., Michishita E., Adler A.S., Damian M., Berber E., Lin M., McCord R.A., Ongaigui K.C.L., Boxer L.D., Chang H.Y., Chua K.F. SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span. Cell 2009, 136:62-74.
20. Kim J.E., Chen J., Lou Z. DBC1 is a negative regulator of SIRT1. Nature 2008, 451:583-586.
21. Kind J., van Steensel B. Genome-nuclear lamina interactions and gene regulation. Curr. Opin. Cell Biol. 2010, 22:320-325.
22. Krishnan V., Chow M.Z.Y., Wang Z., Zhang L., Liu B., Liu X., Zhou Z. Histone H4 lysine 16 hypoacetylation is associated with defective DNA repair and premature senescence in Zmpste24-deficient mice. Proc. Natl. Acad. Sci. USA 2011, 108:12325-12330.
23. Kugel S., Mostoslavsky R. Chromatin and beyond: the multitasking roles for SIRT6. Trends Biochem. Sci. 2014, 39:72-81.
24. Liszt G., Ford E., Kurtev M., Guarente L. Mouse Sir2 homolog SIRT6 is a nuclear ADP-ribosyltransferase. J. Biol. Chem. 2005, 280:21313-21320.
25. Liu B., Zhou Z. Lamin A/C, laminopathies and premature ageing. Histol. Histopathol. 2008, 23:747-763.
26. Liu B., Wang J., Chan K.M., Tjia W.M., Deng W., Guan X., Huang J.D., Li K.M., Chau P.Y., Chen D.J., et al. Genomic instability in laminopathy-based premature aging. Nat. Med. 2005, 11:780-785.
27. Liu B., Ghosh S., Yang X., Zheng H., Liu X., Wang Z., Jin G., Zheng B., Kennedy B.K., Suh Y., et al. Resveratrol rescues SIRT1-dependent adult stem cell decline and alleviates progeroid features in laminopathy-based progeria. Cell Metab. 2012, 16:738-750.
28. Liu C., Lê Cao K.A., Chenevix-Trench G., Simpson P.T., Ragan M.A., Khanna K.K. A fine-scale dissection of the DNA double-strand break repair machinery and its implications for breast cancer therapy. Nucleic Acids Res. 2014, 284:1-21.
29. Luo Y.B., Mastaglia F.L., Wilton S.D. Normal and aberrant splicing of LMNA. J. Med. Genet. 2014, 51:215-223.
30. Luperchio T.R., Wong X., Reddy K.L. Genome regulation at the peripheral zone: lamina associated domains in development and disease. Curr. Opin. Genet. Dev. 2014, 25:50-61.
31. Mangerich A., Bürkle A. Pleiotropic cellular functions of PARP1 in longevity and aging: genome maintenance meets inflammation. Oxid. Med. Cell. Longev. 2012, 2012:321653.
32. Mao Z., Hine C., Tian X., Van Meter M., Au M., Vaidya A., Seluanov A., Gorbunova V. SIRT6 promotes DNA repair under stress by activating PARP1. Science 2011, 332:1443-1446.
33. Mao Z., Tian X., Van Meter M., Ke Z., Gorbunova V., Seluanov A. Sirtuin 6 (SIRT6) rescues the decline of homologous recombination repair during replicative senescence. Proc. Natl. Acad. Sci. USA 2012, 109:11800-11805.
34. McCord R.A., Michishita E., Hong T., Berber E., Boxer L.D., Kusumoto R., Guan S., Shi X., Gozani O., Burlingame A.L., et al. SIRT6 stabilizes DNA-dependent protein kinase at chromatin for DNA double-strand break repair. Aging (Albany, N.Y.) 2009, 1:109-121.
35. McCord R.P., Nazario-Toole A., Zhang H., Chines P.S., Zhan Y., Erdos M.R., Collins F.S., Dekker J., Cao K. Correlated alterations in genome organization, histone methylation, and DNA-lamin A/C interactions in Hutchinson-Gilford progeria syndrome. Genome Res. 2013, 23:260-269.
36. Michishita E., Park J.Y., Burneskis J.M., Barrett J.C., Horikawa I. Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Mol. Biol. Cell 2005, 16:4623-4635.
37. Michishita E., McCord R.A., Berber E., Kioi M., Padilla-Nash H., Damian M., Cheung P., Kusumoto R., Kawahara T.L.A., Barrett J.C., et al. SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin. Nature 2008, 452:492-496.
38. Michishita E., McCord R.A., Boxer L.D., Barber M.F., Hong T., Gozani O., Chua K.F. Cell cycle-dependent deacetylation of telomeric histone H3 lysine K56 by human SIRT6. Cell Cycle 2009, 8:2664-2666.
39. Min L., Ji Y., Bakiri L., Qiu Z., Cen J., Chen X., Chen L., Scheuch H., Zheng H., Qin L., et al. Liver cancer initiation is controlled by AP-1 through SIRT6-dependent inhibition of survivin. Nat. Cell Biol. 2012, 14:1203-1211.
40. Miteva Y.V., Cristea I.M. A proteomic perspective of Sirtuin 6 (SIRT6) phosphorylation and interactions and their dependence on its catalytic activity. Mol. Cell. Proteomics 2014, 13:168-183.
41. Mostoslavsky R., Chua K.F., Lombard D.B., Pang W.W., Fischer M.R., Gellon L., Liu P., Mostoslavsky G., Franco S., Murphy M.M., et al. Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell 2006, 124:315-329.
42. Musich P.R., Zou Y. DNA-damage accumulation and replicative arrest in Hutchinson-Gilford progeria syndrome. Biochem. Soc. Trans. 2011, 39:1764-1769.
43. Olive P.L., Banáth J.P. The comet assay: a method to measure DNA damage in individual cells. Nat. Protoc. 2006, 1:23-29.
44. Pan P.W., Feldman J.L., Devries M.K., Dong A., Edwards A.M., Denu J.M. Structure and biochemical functions of SIRT6. J. Biol. Chem. 2011, 286:14575-14587.
45. Parenti M.D., Grozio A., Bauer I., Galeno L., Damonte P., Millo E., Sociali G., Franceschi C., Ballestrero A., Bruzzone S., et al. Discovery of novel and selective SIRT6 inhibitors. J. Med. Chem. 2014, 57:4796-4804.
46. Prokocimer M., Barkan R., Gruenbaum Y. Hutchinson-Gilford progeria syndrome through the lens of transcription. Aging Cell 2013, 12:533-543.
47. Redwood A.B., Perkins S.M., Vanderwaal R.P., Feng Z., Biehl K.J., Gonzalez-Suarez I., Morgado-Palacin L., Shi W., Sage J., Roti-Roti J.L., et al. A dual role for A-type lamins in DNA double-strand break repair. Cell Cycle 2011, 10:2549-2560.
48. Schreiber K.H., Kennedy B.K. When lamins go bad: nuclear structure and disease. Cell 2013, 152:1365-1375.
49. Sebastián C., Zwaans B.M., Silberman D.M., Gymrek M., Goren A., Zhong L., Ram O., Truelove J., Guimaraes A.R., Toiber D., et al. The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism. Cell 2012, 151:1185-1199.
50. Simeoni F., Tasselli L., Tanaka S., Villanova L., Hayashi M., Kubota K., Isono F., Garcia B.A., Michishita-Kioi E., Chua K.F. Proteomic analysis of the SIRT6 interactome: novel links to genome maintenance and cellular stress signaling. Sci. Rep. 2013, 3:3085.
51. Sullivan T., Escalante-Alcalde D., Bhatt H., Anver M., Bhat N., Nagashima K., Stewart C.L., Burke B. Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy. J. Cell Biol. 1999, 147:913-920.
52. Tennen R.I., Berber E., Chua K.F. Functional dissection of SIRT6: identification of domains that regulate histone deacetylase activity and chromatin localization. Mech. Ageing Dev. 2010, 131:185-192.
53. Toiber D., Erdel F., Bouazoune K., Silberman D.M., Zhong L., Mulligan P., Sebastian C., Cosentino C., Martinez-Pastor B., Giacosa S., et al. SIRT6 recruits SNF2H to DNA break sites, preventing genomic instability through chromatin remodeling. Mol. Cell 2013, 51:454-468.
54. Van Meter M., Mao Z., Gorbunova V., Seluanov A. SIRT6 overexpression induces massive apoptosis in cancer cells but not in normal cells. Cell Cycle 2011, 10:3153-3158.
55. Van Meter M., Mao Z., Gorbunova V., Seluanov A. Repairing split ends: SIRT6, mono-ADP ribosylation and DNA repair. Aging (Albany, N.Y.) 2011, 3:829-835.
56. Van Meter M., Kashyap M., Rezazadeh S., Geneva A.J., Morello T.D., Seluanov A., Gorbunova V. SIRT6 represses LINE1 retrotransposons by ribosylating KAP1 but this repression fails with stress and age. Nat. Commun. 2014, 5:5011.
57. Wazir U., Ahmed M.H., Bridger J.M., Harvey A., Jiang W.G., Sharma A.K., Mokbel K. The clinicopathological significance of lamin A/C, lamin B1 and lamin B receptor mRNA expression in human breast cancer. Cell. Mol. Biol. Lett. 2013, 18:595-611.
58. Zhou J., Liu H., Chen Y., Wen J., Li L., Wu X. Expression and significance of VEGF, miR-205 and target protein Ezrin and Lamin A/C in ovarian cancer. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2014, 39:142-150.